Cabinet Health has invented a refillable and compostable medicine system that uses elevated reusable glass bottles and patented 100% earth-digestible, city-compost-friendly pill packages. The company sells over-the-counter medicines for cold and flu, allergy, digestion, pain, and sleep, all formulated using FDA-approved active ingredients and third-party batch-tested to be free of known carcinogens, toxins, and allergens including gluten. Cabinet plans to expand into prescriptions and retail channels and expects more retail partnerships in 2023. It is a certified B‑Corp that emphasizes minimizing carbon footprint, water waste, and material waste. Financially, Cabinet reports average 110 percent year-over-year growth with its OTC offerings and has raised $17 million in the latest growth funding, bringing total funding to $23.6 million to date. The company was founded in 2018 by Achal Patel and Russell Gong and positions itself to lead the pharmaceutical industry in eliminating single-use plastic medicine packaging.

Total raised

$17M

Funding rounds

2

Latest round

Equity

Latest activity

Dec 2022